{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:48:09Z","timestamp":1763765289777},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2709,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,2,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Omeprazole and lansoprazole are used to treat erosive oesophagitis in the respective daily doses of 20 and 30\u2003mg.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To investigate, by meta\u2010analysis, whether treatment with lansoprazole 30\u2003mg increases erosive oesophagitis healing rates over omeprazole 20\u2003mg.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We searched for randomized, double\u2010blind trials comparing omeprazole 20\u2003mg and lansoprazole 30\u2003mg in endoscopically diagnosed erosive oesophagitis. After assessing for homogeneity, non\u2010heterogeneous trials were combined and pooled healing rates derived. We calculated the relative benefit increase, absolute benefit increase and number needed to treat.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Six trials without significant heterogeneity met predetermined inclusion criteria. By per protocol analysis, pooled healing rates for omeprazole 20\u2003mg and lansoprazole 30\u2003mg were, respectively, 74.7% and 77.7% after 4\u2003weeks and 87.0% and 88.7% after 8\u2003weeks. The corresponding figures by intention\u2010to\u2010treat analysis were 70.8% and 72.7% after 4\u2003weeks and 81.8% and 83.3% after 8\u2003weeks. In each analysis the absolute benefit increase for lansoprazole was small and its 95% confidence interval encompassed zero.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Lansoprazole 30\u2003mg produces healing rates in erosive oesophagitis that are not statistically significantly different to those of omeprazole 20\u2003mg.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00904.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:42Z","timestamp":1047354222000},"page":"227-231","source":"Crossref","is-referenced-by-count":45,"title":["Meta\u2010analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis"],"prefix":"10.1111","volume":"15","author":[{"given":"V. K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. I.","family":"Leontiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199703000-00003"},{"key":"e_1_2_5_5_2","unstructured":"PetittiDB.Meta\u2010analysis decision analysis and cost\u2010effectiveness analysis. Methods for quantitative synthesis in medicine. In: Monographs in Epidemiology and Biostatistics Vol. 24. Oxford: Oxford University Press 1994: 119\u201323."},{"key":"e_1_2_5_6_2","first-page":"A22","article-title":"Glossary","volume":"133","author":"Anonymous","year":"2000","journal-title":"ACP Journal Club"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6977.452"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7168.1309"},{"key":"e_1_2_5_9_2","first-page":"A58","article-title":"Lansoprazole in the acute treatment of reflux esophagitis","volume":"104","author":"Corallo J","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096076"},{"key":"e_1_2_5_11_2","first-page":"1749","article-title":"Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis","volume":"91","author":"Castell DO","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.56198000.x"},{"key":"e_1_2_5_13_2","first-page":"291","article-title":"Efficact\u00e9 compar\u00e9e du lansoprazole et de l\u2019om\u00e9prazole dans le traiement de l\u2032 oesophagite peptique","volume":"24","author":"Petite JP","year":"1995","journal-title":"M\u00e9d Chir Dig"},{"key":"e_1_2_5_14_2","first-page":"A283","article-title":"Comparison of omeprazole, lansoprazole and pantoprazole in the treatment of elderly patients with esophagitis","volume":"116","author":"Pilotto A","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_5_15_2","first-page":"171","article-title":"Lansoprazole versus omeprazole in the treatment of reflux esophagitis","volume":"51","author":"Vcev A","year":"1997","journal-title":"Acta Med Croat"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)23462-4"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199611000-00013"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199120010-00003"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00543502"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05044.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.7.707"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00813.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)82845-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)82148-4"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00904.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00904.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00904.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:33:46Z","timestamp":1697506426000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00904.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2,5]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00904.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00904.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,5]]}}}